✦ LIBER ✦

Survival update of so14999 a large phase III trial of capecitabine/doxetaxel combination therapy vs docetaxel monotherapy in patients with locally advanced (LABC) or metastatic breast cancer (MBC)

✍ Scribed by R. Leonard; G. Cervantes; W. Lui; L. Mauriac; D. Miles; V. Moiseyenko; C. Chan Navarro; G. Van Hazel; S. Vukelja; J. O'Shaughnessy

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5047 Effects on quality of life (QoL) of

✍ F. Nuzzo; F. Di Rella; A. Morabito; A. Gravina; V. Labonia; G. Landi; C. Pacilio 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 62 KB

P.39 Docetaxel plus epirubicin (DE) vs d

✍ Vamvakas, L.; Karampeazis, A.; Ardavanis, A.; Souglakos, I.; Kalbakis, K.; Varda 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB